https://www.selleckchem.com/pr....oducts/tinengotinib.
When adjusted for clinical variables, compared with no diabetes, the hazard ratios (HRs) for MI (95% confidence intervals) were for diabetes on no medication 1.15 (0.62-2.14); for diabetes on non-insulin antidiabetic drugs 1.32 (0.90-1.94); for insulin-treated diabetes 2.34 (1.43-3.82); interaction P = 0.008. HRs for CV death were for diabetes on no medication 1.19 (0.86-166); for diabetes on non-insulin antidiabetic drugs 1.12 (0.88-1.42); for insulin-treated diabetes 1.85 (1.36-2.53), interaction P = 0.001. In anticoagulated pati
Like
Comment
Share
